Skip to main content
LMRI
NASDAQ Industrial Applications And Services

Lumexa Imaging Reports Q2 Profitability, Strong Operating Cash Flow

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$12.295
Mkt Cap
$1.181B
52W Low
$6.45
52W High
$19.45
52W Position info
91% above low
Off High info
37% below high
Rel. Volume info
1.0× avg
Market data snapshot near publication time

LMRI sits 91% above its 52-week low of $6.45.

Summary

Lumexa Imaging Holdings, Inc. reported a significant financial turnaround in Q2 2026, achieving net profitability and strong positive operating cash flow, driven by reduced interest expenses from recent debt refinancing.


Key Events · Earnings and Guidance · LMRI

  • Return to Profitability

    The company achieved net income of $2.7 million in Q2 2026, a significant improvement from a $7.2 million loss in Q2 2025. Year-to-date net income was $4.4 million, reversing a $14.9 million loss from the prior year.

  • Strong Operating Cash Flow

    Generated $35.7 million in net cash from operating activities year-to-date, a substantial improvement from using $11.9 million in the prior year, primarily due to reduced interest payments.

  • Debt Repricing

    Successfully repriced its $825 million Refinancing Term Loan on June 30, 2026, reducing the interest rate from SOFR plus 3.0% to SOFR plus 2.5%, which will further decrease future interest expenses.

  • Ongoing Internal Control Weaknesses

    Management continues to report material weaknesses in internal control over financial reporting, indicating ongoing challenges in financial reporting processes.


Analysis · LMRI · Industrial Applications And Services

Lumexa Imaging Holdings, Inc. has achieved a significant financial turnaround, moving from net losses to profitability and generating substantial positive operating cash flow. This improvement is largely due to reduced interest expenses following recent debt refinancing and a subsequent interest rate reduction. While these financial results are positive, the company continues to face challenges with material weaknesses in internal controls and new litigation stemming from a data breach, which introduce elements of risk.

At the time of this filing, LMRI was trading at $12.30 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $1.2B. The 52-week trading range was $6.45 to $19.45. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

LMRI - Latest Insights

LMRI
Aug 12, 2026, 4:18 PM EDT
Source: Reuters
Importance Score:
7
LMRI
Aug 12, 2026, 4:05 PM EDT
Filing Type: 8-K
Importance Score:
7
LMRI
Jun 30, 2026, 5:13 PM EDT
Source: Wiseek News
Importance Score:
8
LMRI
Jun 30, 2026, 5:08 PM EDT
Filing Type: 8-K
Importance Score:
7
LMRI
Jun 02, 2026, 7:00 AM EDT
Source: GlobeNewswire
Importance Score:
8